PROCTER & GAMBLE HEALTH Financial Statement Analysis
|
||
|
The Revenues of PROCTER & GAMBLE HEALTH have decreased by -18.86% YoY .
The Earnings Per Share (EPS) of PROCTER & GAMBLE HEALTH has increased by 39.46 % YoY. |
||
PROCTER & GAMBLE HEALTH Last 5 Annual Financial Results
[BOM: 500126|NSE : PGHL]
| Standalone | Mar2026 | Mar2025 | Jun2024 | Jun2023 | Jun2022 |
|---|---|---|---|---|---|
| Revenues | ₹934 Cr | ₹1,151 Cr | ₹1,230 Cr | ₹1,114 Cr | ₹1,009 Cr |
| Expenses | ₹616 Cr | ₹845 Cr | ₹905 Cr | ₹847 Cr | ₹763 Cr |
| Operating Profit (Excl OI) | ₹318 Cr | ₹306 Cr | ₹325 Cr | ₹268 Cr | ₹246 Cr |
| Other Income | ₹10 Cr | ₹16 Cr | ₹18 Cr | ₹13 Cr | ₹18 Cr |
| Interest | ₹0.43 Cr | ₹0.72 Cr | ₹0.77 Cr | ₹0.42 Cr | ₹0.80 Cr |
| Depreciation | ₹17 Cr | ₹27 Cr | ₹28 Cr | ₹27 Cr | ₹30 Cr |
| Profit Before Tax | ₹312 Cr | ₹273 Cr | ₹314 Cr | ₹253 Cr | ₹233 Cr |
| Profit After Tax | ₹234 Cr | ₹201 Cr | ₹229 Cr | ₹193 Cr | ₹177 Cr |
| Earnings Per Share (Rs) | ₹196.93 | ₹141.21 | ₹121.07 | ₹138.23 | ₹115.98 |
| PAT Margin (%) | 20.86 | 22.78 | 15.96 | 17.28 | 16.35 |
| ROE(%) | 62.18 | 44.15 | 31.58 | 33.94 | 29.41 |
| ROCE(%) | 84.86 | 58.05 | 42.52 | 46.07 | 38.45 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 8,657.8 Cr |
| Revenue (TTM) | : | ₹ 1,432.9 Cr |
| Net Profit(TTM) | : | ₹ 356.9 Cr |
| EPS (TTM) | : | ₹ 215.0 |
| P/E (TTM) | : | 24.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PROCTER & GAMBLE HEALTH | -1.6% | -7% | -17.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | -6.6% | 7.3% |
| DIVIS LABORATORIES | 1.2% | -2.6% | 60% |
| TORRENT PHARMACEUTICALS | -2% | -6.1% | 33% |
| CIPLA | -2.3% | -5.8% | -13.9% |
| DR REDDYS LABORATORIES | -1.1% | 3.8% | -5.5% |
| MANKIND PHARMA | -4.5% | 2.7% | -2.1% |
| LUPIN | -2.5% | -7.2% | -1.5% |
| ZYDUS LIFESCIENCES | -2.1% | -3% | 12.8% |
PROCTER & GAMBLE HEALTH Revenues
[BOM: 500126|NSE : PGHL]
| Y-o-Y | -18.86 % |
| 5 Yr CAGR | -1.90 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹934 Cr | -18.86 | |
| Mar2025 | ₹1,151 Cr | -6.37 | |
| Jun2024 | ₹1,230 Cr | 10.34 | |
| Jun2023 | ₹1,114 Cr | 10.48 | |
| Jun2022 | ₹1,009 Cr | - | |
PROCTER & GAMBLE HEALTH Operating Profit
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 4.05 % |
| 5 Yr CAGR | 6.66 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹318 Cr | 4.05 | |
| Mar2025 | ₹306 Cr | -5.75 | |
| Jun2024 | ₹325 Cr | 21.29 | |
| Jun2023 | ₹268 Cr | 8.80 | |
| Jun2022 | ₹246 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 28.22 % |
| 5 Yr CAGR | 8.72 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 34.08% | 28.22 | |
| Mar2025 | 26.58% | 0.68 | |
| Jun2024 | 26.4% | 9.91 | |
| Jun2023 | 24.02% | -1.52 | |
| Jun2022 | 24.39% | - | |
PROCTER & GAMBLE HEALTH Profit After Tax
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 16.63 % |
| 5 Yr CAGR | 7.31 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹234 Cr | 16.63 | |
| Mar2025 | ₹201 Cr | -12.42 | |
| Jun2024 | ₹229 Cr | 19.19 | |
| Jun2023 | ₹193 Cr | 8.89 | |
| Jun2022 | ₹177 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -8.43 % |
| 5 Yr CAGR | 6.28 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 20.86 % | -8.43 | |
| Mar2025 | 22.78 % | 42.73 | |
| Jun2024 | 15.96 % | -7.64 | |
| Jun2023 | 17.28 % | 5.69 | |
| Jun2022 | 16.35 % | - | |
PROCTER & GAMBLE HEALTH Earnings Per Share (EPS)
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 39.46 % |
| 5 Yr CAGR | 14.15 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹197 | 39.46 | |
| Mar2025 | ₹141 | 16.64 | |
| Jun2024 | ₹121 | -12.41 | |
| Jun2023 | ₹138 | 19.18 | |
| Jun2022 | ₹116 | - | |
PROCTER & GAMBLE HEALTH Return on Capital Employed (ROCE)
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 46.18 % |
| 5 Yr CAGR | 21.89 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 84.86% | 46.18 | |
| Mar2025 | 58.05% | 36.52 | |
| Jun2024 | 42.52% | -7.71 | |
| Jun2023 | 46.07% | 19.82 | |
| Jun2022 | 38.45% | - | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Current Share Price | : | ₹5,215.6 |
| Current MarketCap | : | ₹ 8,657.8 Cr |
| Updated EOD on | : | Oct 09,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | -1.6% |
-7% |
-17.7% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
PROCTER & GAMBLE HEALTH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | -0.2% | -5.5% | -4.1% |
| BSE HEALTHCARE | -2.2% | -4.8% | 12.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | -0% | -5.5% | -4% |
| NIFTY SMALLCAP 500 | -0.4% | -4.6% | NA |
| NIFTY MICROCAP 250 | -1.5% | -3.9% | 10.1% |
You may also like the below Video Courses
FAQ about PROCTER & GAMBLE HEALTH Financials
How the annual revenues of PROCTER & GAMBLE HEALTH have changed ?
The Revenues of PROCTER & GAMBLE HEALTH have decreased by -18.86% YoY .
How the Earnings per Share (EPS) of PROCTER & GAMBLE HEALTH have changed?
The Earnings Per Share (EPS) of PROCTER & GAMBLE HEALTH has increased by 39.46 % YoY .
Check out Intrinsic Value of Peers of PROCTER & GAMBLE HEALTH
Compare Stock Analytics of Peers of PROCTER & GAMBLE HEALTH
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
